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Four methods are recommended for assessment of iodine nutrition: urinary iodine concentration, the goitre rate, and blood concentrations of thy-
roid stimulating hormone and thyroglobulin. These indicators are complementary, in that urinary iodine is a sensitive indicator of recent iodine
intake (days) and thyroglobulin shows an intermediate response (weeks to months), whereas changes in the goitre rate reflect long-term iodine
nutrition (months to years). Spot urinary iodine concentrations are highly variable from day-to-day and should not be used to classify
iodine status of individuals. International reference criteria for thyroid volume in children have recently been published and can be used for
identifying even small goitres using thyroid ultrasound. Recent development of a dried blood spot thyroglobulin assay makes sample collection
practical even in remote areas. Thyroid stimulating hormone is a useful indicator of iodine nutrition in the newborn, but not in other age groups.
For assessing iron status, haemoglobin measurement alone has low specificity and sensitivity. Serum ferritin remains the best indicator of iron
stores in the absence of inflammation. Measures of iron-deficient erythropoiesis include transferrin iron saturation and erythrocyte zinc protopor-
phyrin, but these often do not distinguish anaemia due to iron deficiency from the anaemia of chronic disease. The serum transferrin receptor is
useful in this setting, but the assay requires standardization. In the absence of inflammation, a sensitive method to assess iron status is to combine
the use of serum ferritin as a measure of iron stores and the serum transferrin receptor as a measure of tissue iron deficiency.
Iodine: Iron: Status: Assessment: Deficiency: Review
Iodine
Four methods are generally recommended for assessment of
iodine nutrition in populations: urinary iodine concentration
(UI), the goitre rate, serum thyroid stimulating hormone
(TSH), and serum thyroglobulin (Tg) (Tables 1 and 2). These
indicators are complementary, in that UI is a sensitive indicator
of recent iodine intake (days) and Tg shows an intermediate
response (weeks to months), whereas changes in the goitre
rate reflect long-term iodine nutrition (months to years).
Thyroid size
Two methods are available for measuring goitre: neck inspec-
tion and palpation, and thyroid ultrasonography. By palpation,
a thyroid is considered goitrous when each lateral lobe has a
volume greater than the terminal phalanx of the thumbs of
the subject being examined. In the classification system of
WHO(1), grade 0 is defined as a thyroid that is not palpable
or visible, grade 1 is a goitre that is palpable but not visible
when the neck is in the normal position (i.e., the thyroid is
not visibly enlarged), and grade 2 goitre is a thyroid that is
clearly visible when the neck is in a normal position. Goitre
surveys are usually done in school age children.
However, palpation of goitre in areas of mild iodine
deficiency has poor sensitivity and specificity; in such areas,
measurement of thyroid volume (Tvol) by ultrasound is
preferable(2). Thyroid ultrasound is non-invasive, quickly done
(2–3min per subject) and feasible even in remote areas using
portable equipment. However, interpretation of Tvol data
requires valid references from iodine-sufficient children. In a
recent multicentre study, Tvol was measured in 6–12 y-old
children (n ¼ 3529) living in areas of long-term iodine suffi-
ciency on five continents. Age- and body surface area- specific
97th percentiles for Tvol were calculated for boys and girls(3).
Goitre can be classified according to these international refer-
ence criteria, but they are only applicable if Tvol is determined
by a standard method(3,4). Thyroid ultrasound is subjective and
requires judgement and experience. Differences in technique
can produce interobserver errors in Tvol as high as 26%(5).
In areas of endemic goitre, although thyroid size predictably
decreases in response to increases in iodine intake, thyroid
size may not return to normal for months or years after correc-
tion of iodine deficiency(6,7). During this transition period, the
goitre rate is difficult to interpret, because it reflects both a
population’s history of iodine nutrition and its present status.
Aghini-Lombardi et al. (6) suggested that enlarged thyroids
in children who were iodine deficient during the first years
of life may not regress completely after introduction of salt
iodization. If true, this suggests that to achieve a goitre rate
,5% in children may require that they grow up under
conditions of iodine sufficiency. A sustained salt iodization
program will decrease the goitre rate by ultrasound to ,5%
in school-age children and this indicates disappearance of
iodine deficiency as a significant public health problem(1).
WHO recommends the total goitre rate be used to define
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severity of iodine deficiency in populations using the
following criteria: ,5%, iodine sufficiency; 5·0%–19·9%,
mild deficiency; 20·0%–29·9%, moderate deficiency; and
.30%, severe deficiency(1) (Table 2).
Urinary iodine concentration
Because .90% of ingested iodine is excreted in the urine,
UI is an excellent indicator of recent iodine intake. UI can
be expressed as a concentration (mg/l), in relationship to
creatinine excretion (mg iodine/g creatinine), or as 24-hour
excretion (mg/day). For populations, because it is impractical
to collect 24 hour samples in field studies, UI can be measured
in spot urine specimens from a representative sample of
the target group, and expressed as the median, in mg/l(1).
Variations in hydration among individuals generally even
out in a large number of samples, so that the median UI in
spot samples correlates well with that from 24 hour samples.
For national, school-based surveys of iodine nutrition, the
median UI from a representative sample of spot urine
collections from <1200 children (30 sampling clusters £ 40
children per cluster) can be used to classify a population’s
iodine status(1) (Table 1).
However, the median UI is often misinterpreted. Individual
iodine intakes, and, therefore, spot UI concentrations are
highly variable from day-to-day(8), and a common mistake is
to assume that all subjects with a spot UI ,100mg/l are
iodine deficient. To estimate iodine intakes in individuals,
24 hour collections are preferable, but difficult to obtain. An
alternative is to use the age-and sex adjusted iodine:creatinine
ratio in adults, but this also has limitations(9). Creatinine may
be unreliable for estimating daily iodine excretion from spot
samples, especially in malnourished subjects where creatinine
concentration is low. Daily iodine intake for population
estimates can be extrapolated from UI, using estimates of
mean 24 hour urine volume and assuming an average iodine
bioavailability of 92% using the formula: Urinary iodine
(mg/l) £ 0·0235 £ body weight (kg) ¼ daily iodine intake(10).
Using this formula, a median UI of 100mg/l in an adult corres-
ponds roughly to an average daily intake of 150mg.
Thyroid stimulating hormone
Because serum thyroid stimulating hormone (TSH) is
determined mainly by the level of circulating thyroid hormone,
which in turn reflects iodine intake, TSH can be used as an
indicator of iodine nutrition. However, in older children and
adults, although serum TSH may be slightly increased by
iodine deficiency, values often remain within the normal
range. TSH is therefore a relatively insensitive indicator of
iodine nutrition in adults(1). In contrast, TSH is a sensitive
indicator of iodine status in the newborn period(11,12). Compared
to the adult, the newborn thyroid contains less iodine but has
higher rates of iodine turnover. Particularly when iodine
supply is low, maintaining high iodine turnover requires
increased TSH stimulation. Serum TSH concentrations are
therefore increased in iodine deficient infants for the first few
weeks of life, a condition termed transient newborn hypothyr-
oidism. In areas of iodine deficiency, an increase in transient
newborn hypothyroidism, indicated by .3% of newborn TSH
values above the threshold of 5mU/l whole blood collected 3
to 4 days after birth, suggests iodine deficiency in the popu-
lation(12). TSH is used in many countries for routine newborn
screening to detect congenital hypothyroidism. If already in
place, such screening offers a sensitive indicator of iodine
nutrition. Newborn TSH is an important measure because it
reflects iodine status during a period when the developing
brain is particularly sensitive to iodine deficiency.
Thyroglobulin
Thyroglobulin (Tg) is synthesized only in the thyroid, and is the
most abundant intrathyroidal protein. In iodine sufficiency,
Table 1. Epidemiological criteria for assessing iodine nutrition in a population based on median and/or range of urinary iodine
concentrations (WHO/UNICEF/ICCIDD, 2007)
Median urinary iodine (mg/l) Iodine intake Iodine nutrition
School-aged children
,20 Insufficient Severe iodine deficiency
20–49 Insufficient Moderate iodine deficiency
50–99 Insufficient Mild iodine deficiency
100–199 Adequate Optimal
200–299 Above requirements Likely to provide adequate intake for pregnant/lactating women,
but may pose a slight risk in the overall population.
.300 Excessive Risk of adverse health consequences (iodine-induced hyperthyroidism,
autoimmune thyroid disease)
Pregnant women
,150 Insufficient
150–249 Adequate
250–499 More than adequate
$500 Excessive*
Lactating women†
,100 Insufficient
$100 Adequate
Children less than 2 years old
,100 Insufficient
$100 Adequate
* The term ‘excessive’ means in excess of the amount required to prevent and control iodine deficiency.
† In lactating women, the figures for median urinary iodine are lower than the iodine requirements because of the iodine excreted in breast milk.
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small amounts of Tg are secreted into the circulation, and serum
Tg is normally ,10mg/l(13). In areas of endemic goitre, serum
Tg increases due to greater thyroid cell mass and TSH stimu-
lation. Serum Tg is well correlated with the severity of iodine
deficiency as measured by UI(14). Intervention studies examin-
ing the potential of Tg as an indicator of response to iodized
oil and potassium iodide have shown that Tg falls rapidly with
iodine repletion, and that Tg is a more sensitive indicator of
iodine repletion than TSH or T4(15,16). However, commer-
cially-available assays measure serum Tg, which requires veni-
puncture, centrifugation and frozen sample transport, which
may be difficult in remote areas.
A new assay for Tg has been developed for dried blood
spots taken by a finger prick(17,18), simplifying collection
and transport. In prospective studies, dried blood spot Tg
has been shown to be a sensitive measure of iodine status
and reflects improved thyroid function within several
months after iodine repletion(17,18). However, several ques-
tions need to be resolved before Tg can be widely adopted
as an indicator of iodine status. One question is the need
for concurrent measurement of anti-Tg antibodies to avoid
potential underestimation of Tg; it is unclear how prevalent
anti-Tg antibodies are in iodine deficiency, or whether they
are precipitated by iodine prophylaxis(19,20). Another limi-
tation is large interassay variability and poor reproducibility,
even with the use of standardization(13). This has made
it difficult to establish normal ranges and/or cutoffs to
distinguish severity of iodine deficiency. However, recently
an international reference range and a reference standard
for DBS Tg in iodine-sufficient school children (4–40mg/l)
has been made available(17) (Table 2).
Thyroid hormone concentrations
In contrast, thyroid hormone concentrations are poor indi-
cators of iodine status. In iodine-deficient populations, serum
T3 increases or remains unchanged, and serum T4 usually
decreases. However, these changes are often within the
normal range, and the overlap with iodine-sufficient popu-
lations is large enough to make thyroid hormone levels an
insensitive measure of iodine nutrition(1).
Table 2. Indicators of iodine status at population level (WHO/UNICEF/ICCIDD, 2007)
Indicator (units) Age group Advantages Disadvantages Application
Median urinary iodine
concentration (mg/l)
School-age children,
adults and pregnant
women
Spot urine samples are
easy to obtain
Relatively low cost
Not useful for individual
assessment
Assesses iodine intake only
over the past few days
See Table 1
External quality control
program in place
Meticulous laboratory practice
needed to avoid contamination
Sufficiently large number of
samples needed to allow for
varying degrees of subject
hydration
Goitre rate by
palpation (%)
School-age
children
Simple and rapid screening
test
Requires no specialized
equipment
Specificity and sensitivity are low
due to a high inter-observer vari-
ation
Responds only slowly to changes
in iodine intake
Degree of IDD by goitre rate:
0–4·9 % – None
5–19·9 % – Mild
20–29·9 % – Moderate
$ 30 % – Severe
Goitre rate by
ultrasound (%)
School-age
children
More precise than palpation Requires expensive equipment
and electricity
Reference values estab-
lished as a function of
age, sex, and body
surface area
Operator needs special training
Responds only slowly to changes
in iodine intake
Thyroid stimulating
hormone (mU/l)
Newborns Measures thyroid function at
a particularly vulnerable
age
Minimal costs if a congenital
hypothyroidism screening
program is already in
place
Collection by heel stick and
storage on filter paper is
simple
Not useful if iodine antiseptics used
during delivery
Requires a standardized, sensitive
assay
Should be taken by heel-prick at
least 48 hours after birth to avoid
physiological newborn surge
A ,3 % frequency of TSH
values .5 mU/l indicates
iodine sufficiency in a
population
Serum or whole blood
thyroglobulin (mg/l)
School-age children
and adults
Collection by finger stick
and storage on filter
paper is simple
Expensive immunoassay
Standard reference material is
available, but needs validation
Reference interval in iodine-
sufficient children is
4–40mg/l
International reference
range available
Measures improving thyroid
function within several
months after iodine
repletion
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Iron
Definitions of iron deficiency states
1. Iron deficiency (ID) is a reduction in body Fe to the
extent that cellular storage Fe required for metabolic/
physiological functions is fully exhausted, with or with-
out anaemia.
2. Iron deficiency anaemia (IDA) is defined as ID and a low
haemoglobin (Hb).
3. Iron-deficient erythropoiesis (IDE) is defined as labora-
tory evidence of a reduced supply of circulating Fe for
erythropoesis, indicated by either reduced Fe saturation
of plasma transferrin or signs of ID in circulating erythro-
cytes. IDE is not synonymous with ID or IDA; IDE can
occur despite normal or even increased storage Fe, due
to impaired release of Fe to the plasma(21). IDE is often
associated with malignancy or inflammation.
Bone-marrow biopsy
Bone-marrow examination to establish the absence of stain-
able iron remains the gold standard for the diagnosis of iron
deficiency, particularly when performed and reviewed under
standardized conditions by experienced investigators. How-
ever, marrow examinations are expensive, uncomfortable,
and require technical expertise, and are not performed routi-
nely in clinical practice.
Haemoglobin
Haemoglobin (Hb) is a widely used screening test for ID, but
used alone has low specificity and sensitivity. Its sensitivity is
low because individuals with baseline Hb values in the upper
range of normal need to lose 20–30% of their body Fe before
their Hb falls below the cut-off for anaemia(21). Its specificity
is low because there are many causes of anaemia other than
ID. Cut-off criteria differ with the age and sex of the indivi-
dual (Table 3), between laboratories, and there are ethnic
differences in normal Hb(22,23).
Mean corpuscular volume and reticulocyte Hb content
Measured on widely-available automated haematology analy-
sers, the mean corpuscular volume (MCV) is a reliable, but
relatively late indicator of ID, and its differential diagnosis
includes thalassemia. The reticulocyte Hb content (CHr) has
been proposed as a sensitive indicator that falls within days
of the onset of IDE(24). However, false normal values can
occur when the MCV is increased or in thalassemia; its
wide use is limited as it can only be measured on one
model of analyzer. For both MCV and CHr, low specificity
limits their clinical utility(25).
Erythrocyte zinc protoporphyrin
Erythrocyte zinc protoporphyrin (ZnPP) increases in IDE
because zinc replaces the missing Fe during formation of
the protoporphyrin ring(26). The ratio of ZnPP/haem can
be measured directly on a drop of blood using a portable
hematofluorometer. In adults, ZnPP has a high sensitivity in
diagnosing iron deficiency(27–32). In infants and children,
ZnPP may also be a sensitive test for detecting iron
deficiency(33–36). However, the specificity of ZnPP in identify-
ing iron deficiency may be limited, because ZnPP can be
increased by lead poisoning, anaemia of chronic disease,
chronic infections and inflammation, haemolytic anaemias,
or haemoglobinopathies(29,37–40). The effect of malaria on
ZnPP in children is equivocal(41–43).
Direct comparisons between studies of ZnPP are difficult
because of interassay variation. Interfering substances in
plasma produced by acute inflammation and haemolysis can
increase ZnPP concentrations 3–4-fold in the absence of
iron deficiency(28). These interfering substances can be
removed by washing the erythrocytes, which markedly
improves assay specificity(28,44); however, this procedure is
not always done because it is time-consuming. Another pro-
blem with ZnPP is that results can be expressed as a concen-
tration (free erythrocyte protoporphyrin, EP, or ZnPP, and
these are not interchangeable) or as the ZnPP-haem molar
ratio; the latter is recommended(45). Several cut-offs have
been proposed for ZnPP to define iron deficiency(28,32,38,46,47).
Using a haematofluorometer on washed erythrocytes, Hastka
et al. (28) recommended a cutoff of .40mmol/mol haem on
the basis of studies in healthy adults. In contrast, other authors,
using unwashed erythrocytes, have proposed a cutoff of
.80mmol to indicate iron deficiency(46,47). ZnPP is a useful
screening test in field surveys, particularly in children,
where uncomplicated ID is the primary cause of anaemia.
Because of the difficulty in automating the assay, ZPP has
been not widely adopted by clinical laboratories.
Transferrin saturation
Transferrin saturation is a widely used screening test for ID,
calculated as the ratio of plasma Fe to total Fe-binding
capacity. Although relatively inexpensive, its use is limited
by diurnal variation in serum Fe and the many clinical
disorders that influence transferrin levels(21).
Serum ferritin
Serum ferritin (SF) may be the most useful laboratory measure
of Fe status; a low value is diagnostic of IDA in a patient with
anaemia (Table 4). In healthy individuals, SF is directly pro-
portional to Fe stores: 1mg/l SF corresponds to 8–10mg
body Fe or 120mg storage Fe/kg body weight(21). It is
widely available, well-standardized, and has repeatedly been
Table 3. Haemoglobin and haematocrit levels by age and gender below
which anaemia is present* (WHO, 2001)
Age or gender group Haemoglobin (g/l) Haematocrit (l/l)
6 mo–59 mo 110 0·33
5–11 y 115 0·34
12–14 y 120 0·36
Nonpregnant women 120 0·36
Pregnant women 110 0·33
Men .15 y 130 0·39
* At altitudes ,1000 m.
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demonstrated to be superior to other measurements for identi-
fying IDA. In a pooled analysis of 2579 subjects using
receiver-operator characteristic curves, the mean area-under-
the-curve for serum ferritin was 0·95, 0·77 for the ZPP, 0·76
for the MCV and 0·74 for transferrin saturation(48). In a
pooled analysis of 9 randomized iron intervention trials
ferritin shows a larger and more consistent response to iron
interventions than ZPP or TfR(49). However, because it is an
acute phase protein, SF is increased independent of Fe status
by acute or chronic inflammation. It is also unreliable in the
setting of malignancy, hyperthyroidism, liver disease, and
heavy alcohol intake.
Serum transferrin receptor
The serum transferrin receptor (TfR) is a transmembrane
glycoprotein that transfers circulating Fe into developing
red cells; <80% of TfR in the body are found on erythroid
precursors. A circulating, soluble form of TfR consists of the
extracellular domain of the receptor. The total mass of cellu-
lar TfR and, therefore, of serum TfR depends both on the
number of erythroid precursors in the bone marrow and on
the number of TfRs per cell, a function of the iron status
of the cell(50,51). Serum TfR concentration appears to be a
specific indicator of IDE that is not confounded by inflam-
mation(52). However, normal expansion of the erythroid
mass during growth(53–55), as well as diseases common in
developing countries, including thalassemia, megaloblastic
anaemia due to folate deficiency, or hemolysis due to
malaria, may increase erythropoiesis and TfR independent
of iron status(56–58). Thus, the diagnostic value of TfR for
IDA is uncertain in children from regions where inflamma-
tory conditions, infection and malaria are endemic(59–61).
The wider application of TfR has been limited by the high
cost of commercial assays. Age-related data for TfR in
children are scarce(62–64), and direct comparison of values
obtained with different assays is difficult because of the
lack of an international standard. A comparison of the ana-
lytical performance of an automated immunoturbidimetric
assay with two manual ELISA assays found good correlations
(r . 0·8); however, TfR values by the immunoturbidimetric
assay were on average 30% lower(65).
TfR/SF ratio
The ratio of TfR/SF can be used to quantitatively estimate
total body Fe(66). The logarithm of this ratio is directly
proportional to the amount of stored Fe in Fe-replete subjects
and the tissue Fe deficit in ID (Table 5). In elderly subjects,
the ratio may be more sensitive than other laboratory tests
for ID(67). However, it cannot be used in individuals with
inflammation because the SF may be elevated independent
of Fe stores, and is assay specific. In a recent analysis of
pooled data from iron intervention studies, calculation of
body iron from the TfR/SF ratio showed no clear advantage
over SF alone(49). Although only validated for adults, the
ratio has also been used in children(68,69). Because TfR
assays are currently not standardized, this affects the use of
the TfR/SF ratio to estimate body iron; the most common
used logarithm is assay specific.
Assessing iron status using multiple indices
The major diagnostic challenge is to distinguish between
IDA in otherwise healthy individuals, and the anaemia of
chronic disease (ACD). Inflammatory disorders increase
circulating hepcidin levels and hepcidin blocks Fe release
from enterocytes and the reticuloendothelial system, resulting
in IDE(70). This can occur despite adequate iron stores. If
chronic, inflammation can produce ACD. The distinction
between ACD and IDA is difficult, as an elevated SF in anae-
mia does not exclude IDA in the presence of inflammation.
A widely-used marker of inflammation is the C-reactive pro-
tein (CRP), but the degree of CRP elevation that invalidates
the use of SF to diagnose ID is uncertain; CRP values
.10–30mg/l have been used. Moreover, during the acute
phase response, the increase in CRP is typically of shorter
duration than the increase in SF. Alternate markers, such as
alpha1-acid glycoprotein (AGP), may be useful, as AGP
levels tend to increase later in infection than CRP, and
remain elevated for several weeks. If anaemia is present
and the CRP is elevated, IDA can usually be diagnosed in
individuals with inflammatory disorders/anaemia of chronic
disease by an elevated TfR and/or ZnPP(21,41). Although
studies in adults have suggested that elevations in TfR(52)
or in ZnPP(28) can be a definitive indicator of iron deficiency,
a recent study in African children found there was large
overlap in the distributions of these indicators in a compari-
son of children with IDA with those with normal iron
status(71). This overlap may be explained by a greater varia-
bility in the erythroid mass in children than in adults,
together with the many variables affecting children in
developing countries that influence TfR and ZnPP indepen-
dent of iron status, as detailed above. Because of this overlap,
the sensitivity and specificity of TfR and ZnPP in identifying
iron deficiency and IDA in children will be modest, regard-
less of the diagnostic cutoffs chosen. Because each test of
iron status has limitations in terms of its sensitivity and
specificity, they have been combined in models to define
iron deficiency. Examples include the model based on low
transferrin saturation and high ZnPP, and the ferritin
model based on low SF and transferrin saturation and
high ZnPP. With these models, specificity increases but
sensitivity is low, and they tend to underestimate ID(47).
When it is feasible to measure several indices, the best
combination is usually Hb, SF and, if CRP is elevated, TfR
and/or ZnPP.
Table 4. Iron status on the basis of serum ferritin concentrations (mg/l)
(WHO, 2001)
,5 y $5 y
Iron status Male Female Male Female
Depleted iron stores ,12 ,12 ,15 ,15
Depleted iron stores
in the presence of
infection
,30 ,30 – –
Risk of iron overload – – .200 (adult) .150 (adult)
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Table 5. The main biochemical indicators of iron deficiency
Unit Commonly used methods
Threshold indicating
iron deficiency Comments
Haemoglobin g/l Cyanmeta using colorimeter or
spectrophotometer or azide-
methhaemoglobin using e.g.
HemoCuew
See Table 3 Used alone, has low specificity
and sensitivity
Thresholds vary by age, gender,
pregnancy, altitude, ethnicity
Haematocrit Decimal ratio or % Centrifugation in capillary tube
or automated flow cytometry
See Table 3 Same as haemoglobin
Blood mean corpuscular
volume (MCV)
fl (10212) Calculated from the haematocrit
and RBC count or automated
flow cytometry
In older children and
adults; ,82 fl
A reliable, but relatively late
indicator of ID
Low values can also be due to
thalassemia and/or inflam-
mation
Blood reticulocyte Hb
concentration
g/l reticulocytes Automated flow cytometry In infants and young
children; ,27·5
A sensitive indicator that falls
within days of onset of IDE
In adults; #28·0 False normal values can occur
when MCV is increased and
in thalassemia
Serum or plasma iron mg/dl Colorimetry (sample from
non-EDTA tube)
,40–50 Varies diurnally and after meals
Low values in chronic disease
Whole blood zinc
protoporphyrin
mmol/mol of heme Fluorescence spectropho-
tometry or portable Avivw
haematofluorimeter
On washed erythrocytes
in children $5 y and
adults; .40
A useful screening test in field
surveys, particularly in children,
where uncomplicated ID is the
primary cause of anaemia
Red cells should be washed
before measurement because
circulating factors, including
serum bilirubin, can spuri-
ously increase values
On unwashed erythrocytes
in children ,5 y; .61
in children $5 y and
adults; .70
Lead poisoning can elevate
values, particularly in urban/
industrial settings
Serum or plasma ferritin mg/l Immunoassay or
immunoturbidometry
See Table 4 Probably the most useful labo-
ratory measure of Fe status;
a low value is diagnostic of
IDA in a patient with anaemia
As an acute phase protein, SF is
increased independent of Fe
status by acute or chronic
inflammation; also unreliable
in subjects with malignancy,
hyperthyroidism, liver disease,
or heavy alcohol intake
Serum or plasma total
iron binding capacity
mg/dl Colorimetric assay of amount
of iron that can be bound to
unsaturated transferrin
in vitro; determination from
transferrin concentration
measured immunologically
.400 Large overlap between normal
values and values in ID
Serum or plasma trans-
ferrin saturation
% Calculated from: Serum
iron/TIBC
,15 % Same as for serum iron
Serum or plasma trans-
ferrin receptor
mg/l Immunoassay or immuno-
turbidometry
Varies with assay Also increased by conditions
with enhanced erythropoesis
Not significantly affected by the
acute phase response, but
may be influenced by malaria,
age and ethnicity
Body iron stores mg/kg body weight Ratio of transferrin receptor to
ferritin : [log (TfR/ferritin
ratio) 2 2·8229]/0·1207
Negative values indicate
tissue iron deficit*
Cannot be used in individuals
with inflammation because
the SF may be elevated
independent of Fe stores
Is assay specific
Although only validated for
adults, is often used in children
* Using RAMCOw ELISA for transferrin receptor.
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